Cefotaxime and desacetylcefotaxime pharmacokinetics in infants and children with meningitis.
about
Pharmacokinetics of cefotaxime and desacetylcefotaxime in infants during extracorporeal membrane oxygenation.Efficacy of gatifloxacin in experimental Escherichia coli meningitis.Relationship of MICs to efficacy of cefotaxime in treatment of Streptococcus pneumoniae infections.Cerebrospinal fluid bactericidal activity against cephalosporin-resistant Streptococcus pneumoniae in children with meningitis treated with high-dosage cefotaxime.Effect of pH on in vitro antimicrobial susceptibility of the Bacteroides fragilis group.Bactericidal activity against intermediately cephalosporin-resistant Streptococcus pneumoniae in cerebrospinal fluid of children with bacterial meningitis treated with high doses of cefotaxime and vancomycin.Antimicrobial activity of ceftriaxone, cefotaxime, desacetylcefotaxime, and cefotaxime-desacetylcefotaxime in the presence of human serum.Efficacy and safety of cefotaxime in the management of pediatric infections.Microdialysis study of cefotaxime cerebral distribution in patients with acute brain injury.Pharmacokinetics of antibacterial agents in the CSF of children and adolescents.Pharmacokinetics and pharmacodynamics of antibacterials, antifungals, and antivirals used most frequently in neonates and infants.Microanalytical high-performance liquid chromatography assay for cefpirome (HR 810) in serum.Pharmacokinetics of cefotaxime and its active metabolite in children with renal dysfunction.Population pharmacokinetics of cefotaxime and dosage recommendations in children with sickle cell disease.Penetration of cefotaxime into cerebrospinal fluid in neonates and young infants.
P2860
Q33826426-27E9C43F-7B74-4258-8E0A-B5C320C18F19Q33977276-4690F1B6-5950-4E69-8DF5-03E8A0F8F029Q35123654-E96F5F1A-BC06-4B7B-9512-F30AEBF61336Q35137976-3089562F-CB6C-4927-8045-F335444448B4Q35138302-EF9E60F8-9E0B-44CD-94AF-2E72121A6212Q35138311-C8D1BB54-F816-4F4D-91AE-66174F32D878Q35540563-94EA443D-9C11-4B16-AF5D-76FE076C3B6BQ36958042-90C02BA7-24EB-46ED-92BE-96805D88E3BFQ37026552-EACBE420-B756-429B-B68A-04D80EFD7D35Q38093135-7729151F-01B0-47FB-8FFE-EA91EF76EFABQ38215682-2D450FFC-17BD-4530-BB5B-E8553D1CEAB3Q39832448-91EA021B-4F85-4584-98F6-81BF64C63ED9Q40087421-B138F8E5-4DEF-4FC5-8F6F-9BA9B2350319Q49598847-1653F316-008F-4852-95BE-51A682B22944Q50044338-F519589A-F639-4B31-8EDA-6D6C5AA69544
P2860
Cefotaxime and desacetylcefotaxime pharmacokinetics in infants and children with meningitis.
description
1985 nî lūn-bûn
@nan
1985年の論文
@ja
1985年論文
@yue
1985年論文
@zh-hant
1985年論文
@zh-hk
1985年論文
@zh-mo
1985年論文
@zh-tw
1985年论文
@wuu
1985年论文
@zh
1985年论文
@zh-cn
name
Cefotaxime and desacetylcefota ...... and children with meningitis.
@ast
Cefotaxime and desacetylcefota ...... and children with meningitis.
@en
type
label
Cefotaxime and desacetylcefota ...... and children with meningitis.
@ast
Cefotaxime and desacetylcefota ...... and children with meningitis.
@en
prefLabel
Cefotaxime and desacetylcefota ...... and children with meningitis.
@ast
Cefotaxime and desacetylcefota ...... and children with meningitis.
@en
P2093
P2860
P356
P1476
Cefotaxime and desacetylcefota ...... and children with meningitis.
@en
P2093
F L Underwood
G L Kearns
R F Jacobs
P2860
P304
P356
10.1128/AAC.28.6.791
P407
P577
1985-12-01T00:00:00Z